MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Personnel Moves: IOM prez steps down from MDT board

March 5, 2014 By MassDevice staff Leave a Comment


New IOM president leaving Medtronic's board

February 21, 2014 by Arezu Sarvestani

Filed Under: News Well Tagged With: BioHeart, ConMed Corp., Hansen Medical Inc., Institute of Medicine, Personnel Moves

Bioheart CEO makes 1st public appearance since emergency cardiac surgery

February 24, 2014 By Arezu Sarvestani Leave a Comment

Bioheart CEO makes 1st public appearance since open-heart surgery

Regenerative therapies maker Bioheart (PINK:BHRT) lauded the return of president & CEO Mike Tomas who underwent emergency open-heart surgery late last year.

Filed Under: News Well Tagged With: BioHeart, Personnel Moves

Neuro Kinetics appoints new CFO | Personnel Moves

December 24, 2013 By Chris Walker Leave a Comment

fired/hired

Neuro Kinetics appointed Michael Saporito as its new CFO.

Saporito joins the Pittsburgh-based medical device company after years with LifeVest, which he helped turn around before the company was bought out by Zoll Medical.

Filed Under: News Well Tagged With: BioHeart, C.R. Bard, Delcath Systems Inc., Insulet, Neuro Kinetics, Personnel Moves, Zoll Medical

Bioheart launches clinical trial for stem cell vision loss therapy

December 17, 2013 By Arezu Sarvestani Leave a Comment

Bioheart launches clinical trial for stem cell vision loss therapy

Filed Under: News Well, Optical/Ophthalmic, Regenerative Medicine, Stem Cells Tagged With: BioHeart, Clinical Trials

Biolase quashes rumors of CEO departure | Personnel Moves

June 10, 2013 By Sony Salzman Leave a Comment

fired/hired

Biolase (NSDQ:BLTI) issued a message to concerned investors, quashing rumors of CEO Federico Pignatelli’s imminent departure and asserting his continued leadership of the dental laser company.

Filed Under: News Well Tagged With: BioHeart, Biolase, Hospira Inc., Johnson and Johnson, Personnel Moves, SafeWire, T2 Biosystems Inc.

Bioheart to ask FDA for “compassionate use” permit for cardiac stem cell therapies

March 27, 2013 By Arezu Sarvestani Leave a Comment

Bioheart Logo

Sunrise, Fla.-based regenerative therapies maker Bioheart Inc. is preparing to ask the FDA to allow "compassionate use" of its cell therapies outside of clinical trial settings.

Bioheart hopes to gain expanded access for its MyoCell and LipiCell treatments in certain heart failure patients who have limited alternative options for treatment, according to a press release.

Filed Under: Food & Drug Administration (FDA), News Well, Regenerative Medicine, Regulatory/Compliance, Stem Cells Tagged With: BioHeart

EndoStim takes funding round to $11M | Wall Street Beat

March 25, 2013 By Brad Perriello Leave a Comment

MassDevice.com Wall Street Beat

EndoStim added another tranche to its $16.5 million equity round, according to a regulatory filing, saying it’s added some $11.2 million to its coffers as it develops a pacemaker-like implant to treat gastro-esophageal reflux disease.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: BioHeart, Clinical Trials, Echo Therapeutics Inc., EndoStim, Intuitive Surgical, Stereotaxis, Stryker

Johnson & Johnson hits 52-week high on boosted earnings forecast | Wall Street Beat

October 16, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Shares of Johnson & Johnson (NYSE:JNJ) surged to a 52-week high today after the healthcare conglomerate boosted its 2012 earnings forecast after reporting a solid, Street-beating quarter (and despite a nearly 18% bottom-line slide).

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: 2012, BioHeart, Corpuls, Healthrageous Inc., InfraReDx Inc., InVivo Therapeutics, Johnson and Johnson, NeuroLogica Corp., Philips, Q3, Steris Corp., Tenaxis Medical, Theragenics Corp., Tissuetech, Welldoc, Wells Fargo, Zoll Medical

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS